Health Condition 1: C50-C50- Malignant neoplasms of breast
Conditions
Interventions
Intervention1: Group D: In addition to induction drugs Group D patients will receive 8mg of single dose intravenous dexamethasone.
Control Intervention1: GroupC: Standard general anaesthesia protocol
Sponsors
Amrita Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18ââ?¬â??60 years, of the American Society of Anaesthesiologists (ASA) physical status 1ââ?¬â??2, undergoing breast surgeries lasting 2-3h under general anaesthesia with laryngeal mask airway will be included in this study.
Exclusion criteria
Exclusion criteria: Patients with an anticipated difficult airway, history of allergy to the test drug, who required more than one attempt at insertion and those with pre-operative sore throat or already on analgesics or steroids (systemic or inhaled) will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary objective is to assess the reduction in incidence and severity of postoperative sore throat in patients undergoing breast surgery under general anaesthesia with laryngeal mask airway in patients.Timepoint: 0,2,4,12,24h in the postoperative period | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives include reduction in incidence of postoperative hoarseness of voice,cough,PONV,pain score and postop analgesic requirement.Timepoint: 0,2,4,12,24 h in the postoperative period | — |
Countries
India
Contacts
Public ContactNitu PV
Amrita Institute of Medical Sciences
Outcome results
None listed